Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Failed Thrombus Aspiration and Decreased Myocardial Perfusion in Patients with STEMI and High Thrombus Load

Half of the patients undergoing percutaneous transluminal coronary angioplasty (PTCA) in a setting of ST-segment elevation acute myocardial infarction (STEMI) experience inadequate myocardial perfusion, known as the no-reflow phenomenon, which contributes to cardiac remodeling and increases mortality. For this reason, effective thrombus removal could reduce the incidence of no-reflow and improve clinical outcomes.

However, studies such as TASTE (Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia) and TOTAL (Trial of Routine Aspiration Thrombectomy with PCI versus PCI Alone in Patients with STEMI) showed no significant clinical benefits derived from the use of thrombus aspiration (TA). Consequently, its routine application is not recommended. Despite this, many operators continue to perform TA in STEMI patients with a high thrombus load.

The objective of this subanalysis of the Gangwon PCI Registry, a prospective, multicenter, observational registry, was to investigate the effect of failed TA on myocardial perfusion and clinical outcomes in STEMI patients with a high thrombus load who underwent PTCA. Additionally, researchers assessed clinical and angiographic predictors associated with TA failure.

The primary endpoint (PE) was the final TIMI angiographic flow after PTCA. The secondary endpoint (SE) included the final myocardial blush grade, electrocardiographic ST-segment resolution, microvascular obstruction, infarct size (measured by cardiac magnetic resonance imaging), all-cause mortality, cardiovascular mortality, stent thrombosis, and treated-vessel revascularization at one month.

The study included a total of 812 STEMI patients with a high thrombus load who underwent PTCA. Of these, 279 had failed TA and 533 had successful TA. Patients with failed TA were older, but there were no significant differences between the groups in terms of gender, risk factors, or time since the onset of infarction.

Read also: Asymmetry in the Implantation of Self-Expanding Valves in TAVR: Evolution at 5 Years.

The proportion of final TIMI flow grade 3 was lower in the failed TA group compared to the successful TA group (74.6% vs. 82.2%; P = 0.011). Similarly, the failed TA group showed lower myocardial perfusion (reduced blush grade), less electrocardiographic ST-segment resolution, and a higher incidence of microvascular obstruction. TA failure was independently associated with lower final TIMI flow (hazard ratio: 1.525; 95% confidence interval [CI]: 1.048-2.218; P = 0.027).

Factors associated with TA failure included older age, Killip class ≥III, vessel tortuosity, calcification, and a culprit vessel other than the left anterior descending artery.

Conclusion

Failed TA was associated with reduced myocardial perfusion in STEMI patients with a high thrombus load who underwent primary PTCA. Older age, hemodynamic instability, tortuosity and calcification of the infarct-related artery, and involvement of arteries other than the left anterior descending artery reduce the effectiveness of thrombus aspiration in a setting of STEMI.

Original Title: Failed Thrombus Aspiration and Reduced Myocardial Perfusion in Patients With STEMI and Large Thrombus Burden.

Reference: Ho Sung Jeon, MD et al JACC Cardiovasc Interv. 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...